Oakland, CA, United States of America

Kyle C Tamshen

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Gilead Sciences, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyle C Tamshen. Retrieved from https://idiyas.com/inventor/kyle-c-tamshen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Kyle C. Tamshen

Introduction

Kyle C. Tamshen is an accomplished inventor based in Oakland, California. She has made significant contributions to the field of pharmaceuticals, particularly through her work on CD73 compounds. With one patent to her name, Tamshen exemplifies the innovative spirit that drives advancements in medical science.

Latest Patents

Tamshen's notable patent involves a compound of Formula I, which includes a pharmaceutically acceptable salt. The specific substituents and their descriptions are detailed within the patent documentation. This innovation has the potential to impact therapeutic approaches in various medical conditions.

Career Highlights

Tamshen is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. Her role at Gilead allows her to work on cutting-edge research and development projects that aim to improve patient outcomes. Her expertise in the field has positioned her as a valuable asset to her team.

Collaborations

Throughout her career, Tamshen has collaborated with esteemed colleagues, including Mark J. Bartlett and Gregory F. Chin. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Kyle C. Tamshen's contributions to the field of pharmaceuticals through her patent on CD73 compounds highlight her role as an innovative inventor. Her work at Gilead Sciences, Inc. and collaborations with other professionals underscore her commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…